Literature DB >> 22890959

Sustainable synthesis and automated deposition: an accessible discovery screening library of fragment-like purines.

Christoph Kamper1, Katharina Korpis, Edgar Specker, Lennart Anger, Martin Neuenschwander, Patrick J Bednarski, Andreas Link.   

Abstract

A sub-library of 88 information-rich lead-like purine derivatives were prepared and deposited in an open access academic screening facility. The rationale for the synthesis of these rigid low complexity structures was the privileged character of the purine heterocycle associated with its inherent probability of interactions with multiple adenine-related targets. Although generally expected to be weak binders in many assays, such fragment-like compounds are estimated to match diverse binding sites. It is suggested that heterocycles with many anchor points for hydrogen bonds can be anticipated to undergo very specific interactions to produce more negative enthalpies and thus provide superior starting points for lead optimization than compounds that owe their activity to entropic effects. The in vitro cytotoxicity of the small compounds on a panel of human cancer cell lines has been investigated and some of them showed marked unselective or selective toxicity. This data may be useful if these fragments are to be incorporated into drug-like structures via metabolically cleavable connections. The sub-library will be implemented as part of the ChemBioNet ( www.chembionet.info ) library, and it is open to screening campaigns of academic research groups striving for a fragment-based approach in their biological assays.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890959     DOI: 10.1007/s11030-012-9386-x

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  11 in total

1.  Enthalpic efficiency of ligand binding.

Authors:  György G Ferenczy; György M Keseru
Journal:  J Chem Inf Model       Date:  2010-09-27       Impact factor: 4.956

2.  Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors.

Authors:  Stefan A Laufer; David M Domeyer; Thomas R F Scior; Wolfgang Albrecht; Dominik R J Hauser
Journal:  J Med Chem       Date:  2005-02-10       Impact factor: 7.446

3.  Non-additivity of functional group contributions in protein-ligand binding: a comprehensive study by crystallography and isothermal titration calorimetry.

Authors:  Bernhard Baum; Laveena Muley; Michael Smolinski; Andreas Heine; David Hangauer; Gerhard Klebe
Journal:  J Mol Biol       Date:  2010-02-12       Impact factor: 5.469

Review 4.  The benefits of constructing leads from fragment hits.

Authors:  N Foloppe
Journal:  Future Med Chem       Date:  2011-07       Impact factor: 3.808

5.  Thermodynamics of ligand binding and efficiency.

Authors:  Charles H Reynolds; M Katharine Holloway
Journal:  ACS Med Chem Lett       Date:  2011-03-23       Impact factor: 4.345

6.  Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines: comparisons with the National Cancer Institute data.

Authors:  Karin Bracht; Renate Grünert; Patrick J Bednarski
Journal:  Anticancer Drugs       Date:  2006-01       Impact factor: 2.248

7.  8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.

Authors:  Catia Lambertucci; Ippolito Antonini; Michela Buccioni; Diego Dal Ben; Dhuldeo D Kachare; Rosaria Volpini; Karl-Norbert Klotz; Gloria Cristalli
Journal:  Bioorg Med Chem       Date:  2009-02-23       Impact factor: 3.641

Review 8.  Do enthalpy and entropy distinguish first in class from best in class?

Authors:  Ernesto Freire
Journal:  Drug Discov Today       Date:  2008-08-26       Impact factor: 7.851

9.  Antimycobacterial agents. 1. Thio analogues of purine.

Authors:  Ashish K Pathak; Vibha Pathak; Lainne E Seitz; William J Suling; Robert C Reynolds
Journal:  J Med Chem       Date:  2004-01-01       Impact factor: 7.446

10.  Synthesis, biological testing, and binding mode prediction of 6,9-diarylpurin-8-ones as p38 MAP kinase inhibitors.

Authors:  Dominik R J Hauser; Thomas Scior; David M Domeyer; Bernd Kammerer; Stefan A Laufer
Journal:  J Med Chem       Date:  2007-04-06       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.